Intranasal gene delivery with a polyethylenimine-PEG conjugate

被引:108
作者
Kichler, A
Chillon, M
Leborgne, C
Danos, O
Frisch, B
机构
[1] CNRS, URA 1923, Genethon 3, F-91002 Evry, France
[2] Fac Pharm, CNRS, UMR 7514, Chim Bioorgan Lab, F-67400 Illkirch Graffenstaden, France
关键词
polyethylenimine; polyethyleneglycol; gene transfer; nasal instillation; solubility;
D O I
10.1016/S0168-3659(02)00080-9
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Polyethylenimines (PEIs) are among the most efficient synthetic DNA carriers. High levels of reporter gene expression can be obtained with these agents on a variety of cells. Nevertheless, the gap between their efficiency and that required for therapeutic approaches is still important. With the aim to improve the in vivo transfection properties of PEIs, we have synthesized a conjugate consisting of the linear polymer of 22 kDa covalently modified with polyethyleneglycol (PEG) residues. The resulting conjugate was able to complex DNA and allowed the preparation of highly concentrated polyplexes, in contrast to non-modified PEIs. Administration by nasal instillation of PEI-PEG/DNA complexes in mice resulted in significant levels of transgene expression. Luciferase activity was greatest 24 h after delivery and decreased thereafter. Our results show that the grafting of PEGS can improve some of the properties of PEIs. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:379 / 388
页数:10
相关论文
共 29 条
[1]   Different strategies for formation of PEGylated EGF-conjugated PEI/DNA complexes for targeted gene delivery [J].
Blessing, T ;
Kursa, M ;
Holzhauser, R ;
Kircheis, R ;
Wagner, E .
BIOCONJUGATE CHEMISTRY, 2001, 12 (04) :529-537
[2]   A VERSATILE VECTOR FOR GENE AND OLIGONUCLEOTIDE TRANSFER INTO CELLS IN CULTURE AND IN-VIVO - POLYETHYLENIMINE [J].
BOUSSIF, O ;
LEZOUALCH, F ;
ZANTA, MA ;
MERGNY, MD ;
SCHERMAN, D ;
DEMENEIX, B ;
BEHR, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (16) :7297-7301
[3]  
Boussif O, 1996, GENE THER, V3, P1074
[4]  
BOUSSIF O, 1996, THESIS U L PASTEUR S
[5]   Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs [J].
Bragonzi, A ;
Dina, G ;
Villa, A ;
Calori, G ;
Biffi, A ;
Bordignon, C ;
Assael, BM ;
Conese, M .
GENE THERAPY, 2000, 7 (20) :1753-1760
[6]   Targeting the urokinase plasminogen activator receptor enhances gene transfer to human airway epithelia [J].
Drapkin, PT ;
O'Riordan, CR ;
Yi, SM ;
Chiorini, JA ;
Cardella, J ;
Zabner, J ;
Welsh, MJ .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (05) :589-596
[7]  
Erbacher P, 1999, J GENE MED, V1, P210
[8]   Sugar-mediated uptake of glycosylated polylysines and gene transfer into normal and cystic fibrosis airway epithelial cells [J].
Fajac, I ;
Briand, P ;
Monsigny, M ;
Midoux, P .
HUMAN GENE THERAPY, 1999, 10 (03) :395-406
[9]   Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1α promoter [J].
Gill, DR ;
Smyth, SE ;
Goddard, CA ;
Pringle, IA ;
Higgins, CF ;
Colledge, WH ;
Hyde, SC .
GENE THERAPY, 2001, 8 (20) :1539-1546
[10]   Polyethylenimine-based intravenous delivery of transgenes to mouse lung [J].
Goula, D ;
Benoist, C ;
Mantero, S ;
Merlo, G ;
Levi, G ;
Demeneix, BA .
GENE THERAPY, 1998, 5 (09) :1291-1295